Skip to main content

The independent medical news service

15-02-2021 | Oncology | News | Article

Radiotherapy activity changed significantly during first COVID-19 peak

The total number of radiotherapy courses delivered in England fell significantly during the first peak of the COVID-19 pandemic but this was accompanied by a rapid increase in the use of hypofractionated regimens, study data show.

12-02-2021 | Oncology | News | Article

COVID-19: More evidence against protective effect of ADT

A large study has failed to find an association between receipt of androgen deprivation therapy and a reduced risk for SARS-CoV-2 infection.

02-02-2021 | Oncology | News | Article

Psychological distress high in patients with cancer during COVID-19 pandemic

Two independent studies presented at the IASLC 2020 World Conference on Lung Cancer have highlighted the heightened psychological distress experienced by patients with cancer – especially those with lung cancer – during the COVID-19 pandemic.

27-01-2021 | Oncology | News | Article

NCCN issues guidance for COVID-19 vaccination in cancer patients

The COVID-19 Vaccination Advisory Committee of the US National Comprehensive Cancer Network has provided preliminary recommendations for COVID-19 vaccinations in people with cancer.

11-01-2021 | Oncology | News | Article

COVID-19 rate ‘low’ in patients receiving anticancer therapy

Patients receiving antitumor treatments may have a higher risk for acquiring SARS-CoV-2 infection than the general population, but overall the incidence appears to be low, say Italian researchers.

23-12-2020 | Oncology | News | Article

COVID-19 triage useful for patients with cancer

Using a triage algorithm can aid the detection of COVID-19 in people with cancer and thus help to keep cancer centers COVID-free, Italian researchers report in Cancer.

15-12-2020 | Rheumatology | News | Article

ACTT-2 trial: Baricitinib shows promise for COVID-19

Adding the JAK inhibitor baricitinib to remdesivir treatment reduces recovery time and improves clinical outcomes in hospitalized patients with moderate-to-severe COVID-19, suggest findings from the ACTT-2 randomized controlled trial.

09-12-2020 | Oncology | News | Article

Cancer survivors may be at high risk for poor COVID-19 outcomes

Having a high prevalence of chronic conditions associated with severe COVID-19 and an increased risk for influenza hospitalization or death may indicate that cancer survivors are at increased risk poor COVID-19 outcomes, UK study data suggest.

03-12-2020 | Oncology | News | Article

Clinical guidance may impact cancer treatment rates during COVID-19

The number of people initiating systemic cancer therapies fell substantially at the start of the COVID-19 pandemic but then recovered rapidly with the implementation of new treatment guidance, UK study data show.

02-12-2020 | Rheumatology | News | Article

Meta-analysis confirms elevated infection risk in SLE

Patients with systemic lupus erythematosus are at greater risk for infections than the general population, shows a meta-analysis.

27-11-2020 | Oncology | News | Article

Cancer patients report changes in care during pandemic

One in three people with cancer experienced changes to their care in the early months of the COVID-19 pandemic, according to a survey of the Dutch PROFILES registry participants.

24-11-2020 | Oncology | News | Article

COVID-19 dampens enthusiasm for cancer trial participation

A survey of cancer survivors shows that almost a fifth would be less likely to participate in a clinical trial during the pandemic due to fears about COVID-19.

19-11-2020 | Oncology | News | Article

Serial COVID-19 screening could help guide continuation of anticancer therapy

Research from the United Arab Emirates suggests that serial screening for SARS-CoV-2 infection in asymptomatic patients with cancer could help guide the continuation of anticancer therapy.

10-11-2020 | Oncology | News | Article

Major impact of COVID-19 pandemic on breast cancer care reported

A survey of Italian breast cancer units has highlighted the severe impact of the global SARS-CoV-2 outbreak on the management of individuals with breast cancer.

05-11-2020 | Oncology | News | Article

OncCOVID model predicts impact of delaying cancer treatment during pandemic

US researchers have developed an integrated, web-based survival model – OncCOVID – that may help clinicians to assess the impact of delayed cancer treatment during the COVID-19 global pandemic.

28-10-2020 | Oncology | News | Article

Cancer diagnosis does not impact COVID-19 IgG seroconversion rates

SARS-CoV-2-specific immunoglobulin G antibody detection rates do not differ significantly between people with cancer and healthy individuals who have either confirmed or suspected COVID-19, Italian study data show.

09-10-2020 | Oncology | News | Article

COVID-19: Matched analysis finds no increased morbidity, mortality in cancer patients

Intensive care admission, ventilation, and mortality rates among people with cancer and SARS-CoV-2 infection do not significantly differ to those among infected people without cancer, US study findings indicate.

15-09-2020 | Oncology | News | Article

COVID-19: High mortality risk for cancer patients confirmed

A pooled analysis has confirmed the high mortality rate among adults with cancer and comorbid COVID-19.

09-09-2020 | Oncology | News | Article

UKCCMP data suggest varying COVID-19 susceptibility, severity by tumor type

In patients with cancer, the risk for and severity of COVID-19 differs by tumor type, indicates an analysis of data from the UK Coronavirus Cancer Monitoring Project.

04-09-2020 | Oncology | News | Article

COVID-19: Consensus ESMO guidelines on managing cancer patients issued

Click through for more information on these recommendations

Image Credits